StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.89−0.03 (-3.28%)

Close on Nov 17, 2026Market cap $50.03MP/E –Yield –

PDS Biotechnology cash

Cash and short-term investments held at the end of each period.

PDS Biotechnology's cash was $5.60M at Jun 30, 2026. For fiscal 2025 it was $26.71M, down 35.9% from the year before. Over ten years it grew -14.6% a year on average. The highest annual figure on record is $130.19M in fiscal 2015.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$26.71M-35.9%
FY2024Dec 31, 2024$41.69M-26.3%
FY2023Dec 31, 2023$56.56M-23.4%
FY2022Dec 31, 2022$73.82M+13.1%
FY2021Dec 31, 2021$65.24M+126.2%
FY2020Dec 31, 2020$28.84M+137.1%
FY2019Dec 31, 2019$12.16M+11628.4%
FY2018Dec 31, 2018$103.70K-41.0%
FY2017Dec 31, 2017$175.88K-99.8%
FY2016Dec 31, 2016$106.40M-18.3%
FY2015Dec 31, 2015$130.19M+848.3%
FY2014Dec 31, 2014$13.73M+74.7%
FY2013Dec 31, 2013$7.86M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.60M-82.4%
Q1 FY2026Mar 31, 2026$21.66M-45.8%
Q4 FY2025Dec 31, 2025$26.71M-35.9%
Q3 FY2025Sep 30, 2025$26.20M-47.3%
Q2 FY2025Jun 30, 2025$31.87M-44.8%
Q1 FY2025Mar 31, 2025$39.98M-40.0%
Q4 FY2024Dec 31, 2024$41.69M-26.3%
Q3 FY2024Sep 30, 2024$49.75M-8.3%
Q2 FY2024Jun 30, 2024$57.73M-4.8%
Q1 FY2024Mar 31, 2024$66.63M+2.2%
Q4 FY2023Dec 31, 2023$56.56M-23.4%
Q3 FY2023Sep 30, 2023$54.25M-24.3%
Q2 FY2023Jun 30, 2023$60.62M+14.4%
Q1 FY2023Mar 31, 2023$65.20M+10.7%
Q4 FY2022Dec 31, 2022$73.82M+13.1%
Q3 FY2022Sep 30, 2022$71.64M+2.7%
Q2 FY2022Jun 30, 2022$52.98M-29.1%
Q1 FY2022Mar 31, 2022$58.88M+135.2%
Q4 FY2021Dec 31, 2021$65.24M+126.2%
Q3 FY2021Sep 30, 2021$69.74M+108.4%
Q2 FY2021Jun 30, 2021$74.75M+341.4%
Q1 FY2021Mar 31, 2021$25.04M+19.0%
Q4 FY2020Dec 31, 2020$28.84M+137.1%
Q3 FY2020Sep 30, 2020$33.47M+92.3%
Q2 FY2020Jun 30, 2020$16.93M-22.1%
Q1 FY2020Mar 31, 2020$21.04M-20.9%
Q4 FY2019Dec 31, 2019$12.16M+11628.4%
Q3 FY2019Sep 30, 2019$17.41M+12100.7%
Q2 FY2019Jun 30, 2019$21.73M+5264.3%
Q1 FY2019Mar 31, 2019$26.59M+3127.0%
Q4 FY2018Dec 31, 2018$103.70K-41.0%
Q3 FY2018Sep 30, 2018$142.67K-99.9%
Q2 FY2018Jun 30, 2018$405.16K-99.6%
Q1 FY2018Mar 31, 2018$824.07K-99.1%
Q4 FY2017Dec 31, 2017$175.88K-99.8%
Q3 FY2017Sep 30, 2017$97.31M-13.7%
Q2 FY2017Jun 30, 2017$108.71M–
Q1 FY2017Mar 31, 2017$95.59M–
Q4 FY2016Dec 31, 2016$106.40M–
Q3 FY2016Sep 30, 2016$112.78M–

More PDS Biotechnology figures

See a number that looks wrong?